Pleap develops medimo, an AI-powered diagnostic support tool that auto-generates chart drafts from clinician–patient conversations. medimo launched in 2023 and has been adopted by over 200 clinics, where it has helped reduce clinician burden and improve workflow efficiency. The company plans to use newly raised funds to enhance product functionality, better address clinical needs, expand facility adoption, and strengthen its team. Pleap was founded in May 2022 and is located in Roppongi Hills, Minato-ku, Tokyo. Its recent pre-Series A raise of approximately ¥150 million increased its total funding to about ¥177 million. Investors and healthcare leaders have publicly commended the team’s execution and the product’s impact on clinical operations.

Total raised

$1M

Funding rounds

1

Latest round

Series A

Latest activity

Mar 2026